AlphAIAlphAI — Financial news for AI agents
financialcontent.comOCT 62 min read$OPCH

Why Option Care Health (OPCH) Stock Is Trading Up Today

Option Care Health (OPCH) shares surged 33.2% pre-market after reports of a potential $5B+ acquisition by McKesson and Clayton Dubilier & Rice. The company's revenue grew 1.3% YoY to $1.35B in Q1 2026, missing estimates, with adjusted EPS of $0.40. Full-year revenue guidance was lowered to $5.73B, below analyst expectations.

Original reporting
financialcontent.com
Published Oct 6, 2026, 2:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 6, 2026, 3:27 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Why Option Care Health (OPCH) Stock Is Trading Up Today — source image
Source · financialcontent.com
Decision brief

The 30-second read

$OPCHBullishHigh
01

Why it matters

The reported near‑term acquisition talks have already moved the stock 33% higher, indicating strong market sensitivity to M&A news in the health‑care services space.

02

Market read

The acquisition rumor creates immediate upside for OPCH and may trigger broader sector re‑rating.

03

What to watch

Regulatory approval risk and integration challenges could temper the upside.

Relevance 9/10Novelty 9/10Timing: pre‑market today

Background

Option Care Health provides infusion services; McKesson is a major pharmaceutical distributor; Clayton Dubilier & Rice is a private‑equity firm.

Company-level read

Ticker impact

$OPCHBullishHigh confidence
Context

Shares jumped 33.2% pre‑market after report that McKesson and Clayton Dubilier & Rice are near a $5B acquisition of Option Care Health.

Expected impact

upward pressure as investors price in a potential takeover premium

Evidence & confidence

A $5B buyout at a premium typically lifts the target's share price; the 33% pre‑market move confirms market reaction.

Market effects

Sector

Potential consolidation in the infusion services and specialty health‑care sector could lift peers.

Regional

U.S. healthcare services market may see increased M&A activity.

Global

Large‑cap buyers like McKesson signal continued appetite for strategic health‑care acquisitions worldwide.

Counterpoint

What could challenge this read

If the deal falls through, the recent price surge could reverse sharply.

Key entities

  • Company
    Option Care Health

    NASDAQ‑listed infusion services provider (OPCH).

  • Company
    McKesson

    Large U.S. pharmaceutical distributor and potential acquirer.

  • Private‑Equity Firm
    Clayton Dubilier & Rice

    Partner in the proposed acquisition.

Read at source← All news

StoryCD&R and McKesson agree to acquire Option Care Health

Also covered by

4 outlets

Related articles

OCT 30
$BTSGHighAI 9/10

BrightSpring Soars 12% on Q3 Beat and Raised 2026 Guidance as Adjusted EBITDA Jumps 42%

BrightSpring Health Services (BTSG) stock rose 12% after Q3 earnings beat estimates, with revenue up 26% to $4.21B and adjusted EBITDA up 42% to $228M. The company raised its 2026 guidance. Gross profit per script increased 27%, and home health census grew 58% due to acquisitions from UnitedHealth's Amedisys and LHC Group. Option Care Health (OPCH) and CVS Health (CVS) report next week, which may indicate if BrightSpring's pricing gains are industry-wide.

finance.yahoo.com6 min
OCT 10
$OPCHMed

Key deals this week: Option Care Health, PTC, Energy Transfer and more

Service Properties Trust (SSVC) received a $2.0B acquisition offer from TKO LLC. Viatris (VTRS) agreed to buy Pacira BioSciences (PCRX) for $1.65B. Option Care Health (OPCH) surged 34% after a $5.8B acquisition deal with CD&R and McKesson (MCK). Energy Transfer (ET) will acquire Vaquero Midstream for $2.625B. Emera (EMA) and Canadian Utilities (CDUAF) agreed to a $10B merger. Cenovus Energy (CVE) will acquire Athabasca Oil (ATHOF) for ~$5.7B.

tradingview.com1 min
OCT 10
$OPCHHighAI 9/10

Option Care Health Sold for $5.8B in CD&R-McKesson Deal

Option Care Health (OPCH) is being acquired by CD&R and McKesson (MCK) for $5.8B, or $32.05 per share, a 37% premium. The deal, expected to close in 2027, values the company at $5.8B. Option Care Health will operate independently post-acquisition. The company reported $5.6B in 2025 revenue and $207.6M in net income, with modest growth in 2026. The acquisition aligns with McKesson's strategy to expand access to innovative therapies.

hoodline.com2 min
OCT 9
$MCKHighAI 9/10

McKesson (MCK) Joins $5.8 Billion Option Care Health (OPCH) Acquisition. Is the Valuation Justified?

McKesson (MCK) is acquiring Option Care Health (OPCH) for $5.8B, including debt, at $32.05 per share, a 37% premium. McKesson and private equity firm CD&R will own 49% and 51% respectively. The deal expands McKesson's specialty healthcare services. McKesson's Q1 2027 revenue was $105.4B, beating estimates, with adjusted EPS up 20% YoY to $9.93. The company raised its fiscal 2027 adjusted EPS guidance to $44.20-$45.00.

finance.yahoo.com2 min
OCT 7
$OPCHHighAI 9/10

Infusion therapy provider being acquired in $5.8 billion deal

Option Care Health (OPCH) is being acquired by CD&R and McKesson in a $5.8 billion deal, expected to close in early 2027. CD&R will hold majority ownership, with McKesson holding a minority stake. Option Care Health shares were trading at $31.02, up from $23.34 before the acquisition news. The company will remain separate but will delist from Nasdaq post-deal.

wfmz.com2 min